biotech
213,228 views
267 Discussing
Hot
Latest
$ARKK DUMPS AI CHIPS FOR BIO 🔥
ARK Invest kept trimming NVIDIA and AMD after Thursday’s tech and crypto ETF selloff, signaling continued de-risking from high-beta growth exposure. The only fresh buy was Arcturus Therapeutics, pointing to a sharp rotation away from crowded AI chip names and toward medical innovation.
Track the liquidity exit. Fading semis can snowball when a flagship allocator keeps selling into weakness. Watch for follow-through pressure in AI names and relative strength in biotech as capital rotates.
This matters because Ark often exposes sentiment shifts before the broader market admits them. When a major risk-taker keeps cutting chips and reaching for biotech, I see that as a real tell that momentum is cooling fast.
Not financial advice. Manage your risk.
#ARKK #NVIDIA #AMD #Biotech #Markets
✦
ARK Invest kept trimming NVIDIA and AMD after Thursday’s tech and crypto ETF selloff, signaling continued de-risking from high-beta growth exposure. The only fresh buy was Arcturus Therapeutics, pointing to a sharp rotation away from crowded AI chip names and toward medical innovation.
Track the liquidity exit. Fading semis can snowball when a flagship allocator keeps selling into weakness. Watch for follow-through pressure in AI names and relative strength in biotech as capital rotates.
This matters because Ark often exposes sentiment shifts before the broader market admits them. When a major risk-taker keeps cutting chips and reaching for biotech, I see that as a real tell that momentum is cooling fast.
Not financial advice. Manage your risk.
#ARKK #NVIDIA #AMD #Biotech #Markets
✦
🧬 Global Market Shapers: Top 10 South Asian Scientists by Economic Impact
In the modern age, laboratory breakthroughs move markets faster than central bank announcements. These 10 South Asian scientists have pioneered discoveries that control trillions of dollars in global trade, pharmaceuticals, and biotechnology.
1. Prof. Malik Peiris (Sri Lanka) – Virology
* Market Impact: Global Pandemic Economics. As the first to identify the SARS virus and a leader in H5N1 research, his work is the foundation for global pandemic preparedness. His findings dictate the movement of the $100B+ vaccine market and global travel/insurance indices.
2. Dr. M.S. Swaminathan (India) – Genetics/Agriculture
* Market Impact: Global Commodities & Agri-Trade. The architect of the Green Revolution. His genetic work on high-yield crops literally feeds billions and stabilizes the global prices of wheat and rice on international commodity exchanges.
3. Sir Venki Ramakrishnan (India/UK) – Molecular Biology
* Market Impact: The Antibiotic Industry. A Nobel Laureate whose structural mapping of the ribosome is the "master key" for modern antibiotic drug design. This discovery underpins a massive segment of the global pharmaceutical industry.
4. Dr. Soumya Swaminathan (India) – Public Health & Policy
* Market Impact: Healthcare Regulation & Funding. As the former Chief Scientist of the WHO, her clinical and policy frameworks directed the global allocation of hundreds of billions of dollars in health aid and vaccine procurement.
5. Prof. Neelika Malavige (Sri Lanka) – Immunology
* Market Impact: Tropical Medicine & Pharma R&D. Her world-class research on Dengue and COVID-19 immunology is vital for Big Pharma's drug development pipeline, impacting market valuations for infectious disease treatments.
6. Dr. Har Gobind Khorana (India/USA) – Genetics
* Market Impact: The Biotech Revolution. Nobel Laureate who cracked the genetic code. His work is the DNA of the modern $400B+ biotechnology industry, including gene synthesis and personalized medicine.
7. Prof. Atta-ur-Rahman (Pakistan) – Organic Chemistry
* Market Impact: Natural Product Pharmaceuticals. One of the world's leading experts in chemistry whose work has led to the synthesis of numerous compounds used in the multi-billion dollar medicinal and herbal industries.
8. Dr. Firdausi Qadri (Bangladesh) – Immunology
* Market Impact: Vaccine Manufacturing & Distribution. Her work in mass-scale, affordable vaccine development for cholera and typhoid directly affects public health budgets and the pharmaceutical supply chain in developing economies.
9. Dr. Yellapragada Subbarow (India) – Biochemistry
* Market Impact: Oncology & Drug Markets. The pioneer behind Methotrexate (chemotherapy) and ATP. His discoveries remain a cornerstone of the global cancer treatment market, valued at hundreds of billions of dollars.
10. Prof. Asis Datta (India) – Molecular Biology
* Market Impact: Food Technology & GMOs. A leader in plant genomics whose research influences the development of genetically modified organisms (GMOs) and the valuation of global Agrotech companies.
Strategic Insight for Investors:
* Bio-Capitalism: We are moving from a Silicon-based economy to a Carbon-based (Biological) economy.
* Intellectual Moat: South Asian scientists hold the "Intellectual Property" (IP) that secures global food and health systems.
* Market Signals: Breakthroughs from these labs are leading indicators for stock volatility in the Healthcare and Consumer Staples sectors.
#Biotech #globaleconomy #India #Pakistan #Write2Earn
1. Prof. Malik Peiris (Sri Lanka) – Virology
* Market Impact: Global Pandemic Economics. As the first to identify the SARS virus and a leader in H5N1 research, his work is the foundation for global pandemic preparedness. His findings dictate the movement of the $100B+ vaccine market and global travel/insurance indices.
2. Dr. M.S. Swaminathan (India) – Genetics/Agriculture
* Market Impact: Global Commodities & Agri-Trade. The architect of the Green Revolution. His genetic work on high-yield crops literally feeds billions and stabilizes the global prices of wheat and rice on international commodity exchanges.
3. Sir Venki Ramakrishnan (India/UK) – Molecular Biology
* Market Impact: The Antibiotic Industry. A Nobel Laureate whose structural mapping of the ribosome is the "master key" for modern antibiotic drug design. This discovery underpins a massive segment of the global pharmaceutical industry.
4. Dr. Soumya Swaminathan (India) – Public Health & Policy
* Market Impact: Healthcare Regulation & Funding. As the former Chief Scientist of the WHO, her clinical and policy frameworks directed the global allocation of hundreds of billions of dollars in health aid and vaccine procurement.
5. Prof. Neelika Malavige (Sri Lanka) – Immunology
* Market Impact: Tropical Medicine & Pharma R&D. Her world-class research on Dengue and COVID-19 immunology is vital for Big Pharma's drug development pipeline, impacting market valuations for infectious disease treatments.
6. Dr. Har Gobind Khorana (India/USA) – Genetics
* Market Impact: The Biotech Revolution. Nobel Laureate who cracked the genetic code. His work is the DNA of the modern $400B+ biotechnology industry, including gene synthesis and personalized medicine.
7. Prof. Atta-ur-Rahman (Pakistan) – Organic Chemistry
* Market Impact: Natural Product Pharmaceuticals. One of the world's leading experts in chemistry whose work has led to the synthesis of numerous compounds used in the multi-billion dollar medicinal and herbal industries.
8. Dr. Firdausi Qadri (Bangladesh) – Immunology
* Market Impact: Vaccine Manufacturing & Distribution. Her work in mass-scale, affordable vaccine development for cholera and typhoid directly affects public health budgets and the pharmaceutical supply chain in developing economies.
9. Dr. Yellapragada Subbarow (India) – Biochemistry
* Market Impact: Oncology & Drug Markets. The pioneer behind Methotrexate (chemotherapy) and ATP. His discoveries remain a cornerstone of the global cancer treatment market, valued at hundreds of billions of dollars.
10. Prof. Asis Datta (India) – Molecular Biology
* Market Impact: Food Technology & GMOs. A leader in plant genomics whose research influences the development of genetically modified organisms (GMOs) and the valuation of global Agrotech companies.
Strategic Insight for Investors:
* Bio-Capitalism: We are moving from a Silicon-based economy to a Carbon-based (Biological) economy.
* Intellectual Moat: South Asian scientists hold the "Intellectual Property" (IP) that secures global food and health systems.
* Market Signals: Breakthroughs from these labs are leading indicators for stock volatility in the Healthcare and Consumer Staples sectors.
#Biotech #globaleconomy #India #Pakistan #Write2Earn
AI CANCER BREAKTHROUGH SHOCKS BIOTECH $AI 🧬
An Australian entrepreneur used AI and 300GB of genetic data to prototype a personalized mRNA cancer vaccine for a pet dog, with early signs of improvement. The significance is institutional: it validates faster, lower-cost precision medicine workflows and strengthens the case for AI-driven biotech platforms, diagnostics, and personalized therapeutics.
Not financial advice. Manage your risk.
#Biotech #Aİ #MolecularMedicine #PrecisionMedicine #HealthTech
✦
An Australian entrepreneur used AI and 300GB of genetic data to prototype a personalized mRNA cancer vaccine for a pet dog, with early signs of improvement. The significance is institutional: it validates faster, lower-cost precision medicine workflows and strengthens the case for AI-driven biotech platforms, diagnostics, and personalized therapeutics.
Not financial advice. Manage your risk.
#Biotech #Aİ #MolecularMedicine #PrecisionMedicine #HealthTech
✦
$XBI JUST GOT A LIVE PROOF OF CONCEPT
An Australian entrepreneur used AI and 300GB of genetic data to build a personalized mRNA cancer vaccine for his dog, with early signs of improvement. The institutional signal is bigger than the pet case: faster, cheaper precision medicine could compress development timelines and pull biotech, insurance, and AI infrastructure deeper into the same trade.
Not financial advice. Manage your risk.
#Biotech #Aİ #mRNA #PrecisionMedicine #Healthcare
✦
An Australian entrepreneur used AI and 300GB of genetic data to build a personalized mRNA cancer vaccine for his dog, with early signs of improvement. The institutional signal is bigger than the pet case: faster, cheaper precision medicine could compress development timelines and pull biotech, insurance, and AI infrastructure deeper into the same trade.
Not financial advice. Manage your risk.
#Biotech #Aİ #mRNA #PrecisionMedicine #Healthcare
✦
AI IS BUILDING CANCER VACCINES FOR PETS $AI ⚡
Australian entrepreneur Paul Conyngham is using AI to design personalized mRNA cancer vaccines for pets, built on 300GB of genetic data. Early signs from Rosie suggest the approach is showing real-world improvement, putting personalized biotech and AI-driven drug design in the spotlight for institutional attention.
Not financial advice. Manage your risk.
#Crypto #Aİ #Biotech #MemeCoins
✦
Australian entrepreneur Paul Conyngham is using AI to design personalized mRNA cancer vaccines for pets, built on 300GB of genetic data. Early signs from Rosie suggest the approach is showing real-world improvement, putting personalized biotech and AI-driven drug design in the spotlight for institutional attention.
Not financial advice. Manage your risk.
#Crypto #Aİ #Biotech #MemeCoins
✦
AI MAKES CANCER VACCINES PERSONAL FOR PETS $AI 🚨
Australian entrepreneur Paul Conyngham is using AI and 300GB of genetic data to develop personalized mRNA cancer vaccines for pets. Early signs of improvement in Rosie suggest a potential breakthrough in veterinary biotech and could accelerate investor attention toward AI-driven personalized medicine.
Not financial advice. Manage your risk.
#Aİ #Biotech #mRNA #Innovation #PetHealth
⚡
Australian entrepreneur Paul Conyngham is using AI and 300GB of genetic data to develop personalized mRNA cancer vaccines for pets. Early signs of improvement in Rosie suggest a potential breakthrough in veterinary biotech and could accelerate investor attention toward AI-driven personalized medicine.
Not financial advice. Manage your risk.
#Aİ #Biotech #mRNA #Innovation #PetHealth
⚡
$YZI JUST OPENED A $1MBABYDOGE DEALFLOW GATE
YZI Labs launched Atlas Scout, a student-managed $1 million venture program backing 5 to 10 top university investors in Web3, AI, and biotech. The initiative expands early-stage dealflow and gives selected students direct access to YZi Labs’ 300-plus portfolio ecosystem, signaling a stronger push into emerging founder networks.
Not financial advice. Manage your risk.
#Web3 #Aİ #Biotech #VentureCapital #Startups
⚡
YZI Labs launched Atlas Scout, a student-managed $1 million venture program backing 5 to 10 top university investors in Web3, AI, and biotech. The initiative expands early-stage dealflow and gives selected students direct access to YZi Labs’ 300-plus portfolio ecosystem, signaling a stronger push into emerging founder networks.
Not financial advice. Manage your risk.
#Web3 #Aİ #Biotech #VentureCapital #Startups
⚡
YZI LABS JUST UNLOCKED A NEW DEAL FLOW ENGINE $YZI 🚨
Institutional capital is moving earlier in the funnel as YZi Labs launches a $1MBABYDOGE student-managed VC program spanning Web3, AI, and biotech. The Atlas Scout Program gives top university students direct access to 300+ portfolio projects, signaling a sharper push to source, back, and shape the next wave of founders.
Not financial advice. Manage your risk.
#Web3 #Aİ #VentureCapital #Biotech #Startups
✦
Institutional capital is moving earlier in the funnel as YZi Labs launches a $1MBABYDOGE student-managed VC program spanning Web3, AI, and biotech. The Atlas Scout Program gives top university students direct access to 300+ portfolio projects, signaling a sharper push to source, back, and shape the next wave of founders.
Not financial advice. Manage your risk.
#Web3 #Aİ #VentureCapital #Biotech #Startups
✦
$YZI DROPS $1MBABYDOGE VC WAR CHEST ON STUDENTS 🚨
YZI Labs is launching Atlas Scout, a student-managed VC fund backed by up to $1MBABYDOGE to back early-stage Web3, AI, and Biotech startups. The move gives top university students direct investment authority under YZi oversight, signaling a sharper institutional hunt for early founder access and conviction capital.
Not financial advice. Manage your risk.
#Web3 #Aİ #Biotech #VentureCapital #Startups
⚡
YZI Labs is launching Atlas Scout, a student-managed VC fund backed by up to $1MBABYDOGE to back early-stage Web3, AI, and Biotech startups. The move gives top university students direct investment authority under YZi oversight, signaling a sharper institutional hunt for early founder access and conviction capital.
Not financial advice. Manage your risk.
#Web3 #Aİ #Biotech #VentureCapital #Startups
⚡
🤖An idea of monetization and tokenization of pharmaceutical product royalties
1.Fundraising as a fund.
2.Monetization - Invest the royalties of drugs still in the R&D phase.
3.Tokenization - design a token distribution plan that should cover the clinical volunteer community.
4.Return the tokens to the GPs and LPs of the fund, and start the public trading. Keep updated with the announcements of the timely clinical research progress.
This design would enable pharmaceutical startups, LPs, and doctor-patient communities to realize value returns while shortening the capital cycle.
We are committed to integrating web3 with biotech for a more comprehensive development.
#Biotech
1.Fundraising as a fund.
2.Monetization - Invest the royalties of drugs still in the R&D phase.
3.Tokenization - design a token distribution plan that should cover the clinical volunteer community.
4.Return the tokens to the GPs and LPs of the fund, and start the public trading. Keep updated with the announcements of the timely clinical research progress.
This design would enable pharmaceutical startups, LPs, and doctor-patient communities to realize value returns while shortening the capital cycle.
We are committed to integrating web3 with biotech for a more comprehensive development.
#Biotech
Positive
100%
Negative
0%
1 votes • Voting closed
Here’s a more creative and attractive Binance Square post for $BIO 👇
🚀 $BIO
– Where Biotech Meets Blockchain 🔬💎
While meme coins come and go, $BIO is building real-world utility. Combining Biotechnology + Blockchain, this project is tapping into a trillion-dollar future industry. 🌍✨
👉 The smart money moves early. Are you in before Wall Street notices?
#BIO #Biotech #CryptoGems #Altcoins #BinanceSquare
– Where Biotech Meets Blockchain 🔬💎
While meme coins come and go, $BIO is building real-world utility. Combining Biotechnology + Blockchain, this project is tapping into a trillion-dollar future industry. 🌍✨
👉 The smart money moves early. Are you in before Wall Street notices?
#BIO #Biotech #CryptoGems #Altcoins #BinanceSquare
BIO Coin The Sleeper Giant About to Explode! 🔥
Current Price: 0.14
A simple $100 investment = 161 BIO
If BIO hits $50 in the next bull run → $8,050 💰
If BIO goes to $200 → $32,200 🚀
Millionaires are made from coins like this, not after the hype but before it starts!
Click here to buy $BIO now
#Biotech
Current Price: 0.14
A simple $100 investment = 161 BIO
If BIO hits $50 in the next bull run → $8,050 💰
If BIO goes to $200 → $32,200 🚀
Millionaires are made from coins like this, not after the hype but before it starts!
Click here to buy $BIO now
#Biotech
$BIO Token is a blockchain-based utility token focused on revolutionizing healthcare and biotech data management.
Its bullish move is driven by growing adoption in medical research and decentralized data storage.
🔶 Tokenomics include a fixed supply of 1 billion tokens:-
✅40% for public sale ✅20% for ecosystem growth
✅20% for development
✅10% for partnerships
✅10% reserved.
Staking rewards, low transaction fees, and utility in data licensing add long-term value and investor confidence.
$BTC
#BIO #Biotech #BİO #bnb #BTC
Its bullish move is driven by growing adoption in medical research and decentralized data storage.
🔶 Tokenomics include a fixed supply of 1 billion tokens:-
✅40% for public sale ✅20% for ecosystem growth
✅20% for development
✅10% for partnerships
✅10% reserved.
Staking rewards, low transaction fees, and utility in data licensing add long-term value and investor confidence.
$BTC
#BIO #Biotech #BİO #bnb #BTC
dear Bainance team plzz action against shell coin and bio coin its hamble request plzz ask shell and bio to stop urs scame #shellprice and #Biotech action again$SHELL
Recent Trades
0 trades
BIO/USDT
---
Is BIO “Down by today, buy now”?
$BIO No, BIO is not down today—it’s up, currently trading higher than the previous day’s close.
Whether it’s a good time to buy depends on your investing goals, risk appetite, and timeframe.
Bull Case: Analysts suggest upside potential remains, with targets ranging from ~$325 to $353+, possibly up to $480 .
Caution: The stock is still significantly below its 52-week high, and investing involves risk.$BIO
#BIO #Biotech #BiotechInnovation #cryptouniverseofficial #Crypto_Jobs🎯
Is BIO “Down by today, buy now”?
$BIO No, BIO is not down today—it’s up, currently trading higher than the previous day’s close.
Whether it’s a good time to buy depends on your investing goals, risk appetite, and timeframe.
Bull Case: Analysts suggest upside potential remains, with targets ranging from ~$325 to $353+, possibly up to $480 .
Caution: The stock is still significantly below its 52-week high, and investing involves risk.$BIO
#BIO #Biotech #BiotechInnovation #cryptouniverseofficial #Crypto_Jobs🎯
$BIO presents a compelling long-term investment opportunity, despite recent short-term volatility driven by broader market conditions. Critics often misunderstand $BIO , viewing it as just another meme coin or spreading fear for profit, but its alignment with the DECSCI narrative and support from Binance adds significant credibility. While the current market downturn, particularly in $BTC , has put downward pressure on altcoins like BIO, the project’s potential remains strong, especially if #DECSCI gains market traction. For long-term holders, this price dip should be viewed as a temporary setback, as BIO's fundamentals and backing by major players like Binance suggest its value could rise significantly in the future. Traders should focus on BIO’s long-term prospects rather than getting caught up in short-term fluctuations.
#Biotech #biousdt #AIXBT,COOKIE,CGPTOnBinance #USJobsSurge256K
#Biotech #biousdt #AIXBT,COOKIE,CGPTOnBinance #USJobsSurge256K
🐕 #Biotech is the talk of the TOWN , #BIO hits almost 50% in 24 hrs window. Will it accelerate to the ATH during this #altsesaon ?
🐕Cryptocurrency investments carry risks. Therefore, this is not financial advice (No BSH recommendation). Hence please do your own research (DYOR) before making investment decisions.
#Write2Earn
#Write2Earn!
$BIO
🐕Cryptocurrency investments carry risks. Therefore, this is not financial advice (No BSH recommendation). Hence please do your own research (DYOR) before making investment decisions.
#Write2Earn
#Write2Earn!
$BIO
🧬 $BIO – Blockchain + Biotech Future 🔥
BIO combines biotechnology & blockchain 🧪
This is a market trillions worth — imagine holding BIO early 👀
BIO is not just hype, it’s utility + innovation.
Click here to buy $BIO and enjoyyy
#Biotech #MarketPullback #CryptoRally
BIO combines biotechnology & blockchain 🧪
This is a market trillions worth — imagine holding BIO early 👀
BIO is not just hype, it’s utility + innovation.
Click here to buy $BIO and enjoyyy
#Biotech #MarketPullback #CryptoRally
$BIO = biotech 🔬 + blockchain ⛓️ = rare formula for massive growth.
👉 Click here to buy $BIO and enjoyyy
#Biotech #CryptoRally
👉 Click here to buy $BIO and enjoyyy
#Biotech #CryptoRally
My Assets Distribution
USDT
ENA
Others
76.35%
22.93%
0.72%
Login to explore more contents